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Avaliação Cognitiva Breve da Filadélfia numa amostra brasileira clínica e saudável
Danilo Assis Pereira1,2, Corina Satler2, Luciana Medeiros3, Renan Pedroso3, Carlos Tomaz4
Dementia assessment implies measuring cognitive func-
tions and some instruments have been used in Brazil for this 
purpose. One of the most frequently used is the Mini-Mental 
State Examination (MMSE)1, a short screening assessment 
of cognitive impairment. This success is due to the fact that it 
requires only 5-10 minutes to be administered and has good 
reliability2.
However, MMSE presents some limitations3. For exam-
ple, it emphasizes function rather than verbal skills and non-
dominant hemisphere executive functions. This indicates 
that MMSE may be of little screening use for frontal execu-
tive dysfunction and visuospatial deficits4. This is a major flaw 
if one considers the important role of executive functions in 
early clinical stages of dementia3. Another limitation is that 
the MMSE has a low sensitivity for patients with mild mem-
ory deficits5, since only three words are required to be re-
membered in the recall task. Finally, MMSE does not analyze 
behavioral changes, which are important in Alzheimer’s dis-
ease (AD) and frontotemporal dementia (FTD) diagnosis6,7. 
Therefore, MMSE may not be sufficient to assess the severity 
of clinical course of other types of dementia8.
Considering these MMSE limitations, Dr. David Libon cre-
ated in 2007 the Philadelphia Brief Assessment of Cognition 
(PBAC), a neuropsychological screening instrument sensi-
tive to neuropsychological deficits associated with AD and 
patients with FTD dementia7. It is easy to apply and can be 
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ABSTRACT
The Philadelphia Brief Assessment of Cognition (PBAC) is a neuropsychological screening instrument that assesses five cognitive domains: 
working memory, visuospatial functioning, language, episodic memory and comportment. The aim is to verify if PBAC can properly be used 
in the Brazilian sample. Participated in this study: (a) 200 healthy volunteers - 100 young [21.6(2.5) years old] and 100 older adults [70.1(7.3) 
years old]; >12 years of education; (b) 30 Alzheimer’s patients (AD) [73.7(5.7) years old], 4-11 years in education. The PBAC scores: (a) 95.8(2.6), 
90.0(4.4) and (b) 65.0(10.8) were correlated with the Mini-Mental State Examination (MMSE) for young 29.1(0.9), older adults 28.3(1.4) and AD 
18.4(3.0) groups. A positive correlation between MMSE and PBAC (r=0.9, p<0.001) was found. Negative correlations were observed between 
PBAC domains [memory (-0.63), visuospatial abilities (-0.44) and working memory (-0.3) tasks]. MANOVA showed a better male performance in 
visuospatial functioning (F=8.5, p=0.004). The Brazilian version of PBAC proved to be a promising screening instrument for clinical purposes.
Key words: Philadelphia Brief Assessment of Cognition, Alzheimer´s disease, cognition, dementia.
RESUMO
O instrumento de rastreio neuropsicológico Philadelphia Brief Assessment of Cognition (PBAC) avalia cinco domínios cognitivos: memória de 
trabalho, habilidade visuoespacial, linguagem, memória episódica e comportamento. O objetivo é verificar a viabilidade do PBAC em amostra 
brasileira. Participaram: (a) 200 voluntários - 100 jovens com 21,6(2,5) anos e 100 idosos com 70,1(7,3) anos, ambos com média de escolari-
dade maior que 12 anos; (b) 30 pacientes com Alzheimer, com 73,7(5,7) anos e escolaridade entre 4 e 11 anos. Os escores do PBAC para os 
respectivos grupos (a) 95,8(2,6), 90(4,4) e (b) 65(10,8) foram correlacionados com o Mini Exame do Estado Mental (MEEM). Houve correlação 
positiva (r=0,9; p<0,001) entre MEEM e PBAC, e negativas entre os domínios do PBAC [memória (-0,63), habilidades visuoespaciais (-0,44) 
e memória de trabalho (-0,3)]. Foi demonstrado pela MANOVA melhor desempenho no funcionamento visuoespacial em homens (F=8,5, 
p=0,004). A versão brasileira do PBAC provou ser promissora como um instrumento de rastreio para propósitos clínicos.
Palavras-Chave: Philadelphia Brief Assessment of Cognition, doença de Alzheimer, cognição, demência.
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administered quickly, lasting about 15 to 20 minutes. In com-
parison with other brief batteries, the PBAC presents some ad-
vantages: it provides more detailed information about those 
cognitive functions that are impaired or preserved, as well as 
having greater sensitivity to a broad spectrum of dementias. 
The 23 tasks are grouped into 5 functioning domains, each 
one evaluating different cognitive areas. These are: working 
memory/mental search, visuospatial functioning, language, 
verbal/visual episodic memory and social comportment/be-
havior. The total PBAC (3th brief version, 2010) score ranges 
between 0 and 100. Its first version (2007) ranged between 0 
and 126. Recently, the PBAC has been used to determine pat-
terns of neuropsychological impairment in FTD6.
The aim of this work is to test the PBAC (3th version) into 
a Brazilian sample looking for aging effects by comparing 
young and old adults. The sensitivity of PBAC to determine 
severity of Alzheimer’s disease was assessed by correlating 
the total PBAC score with the MMSE.
METhOdS
Subjects
Comparison sample was formed by 200 healthy volun-
teers: 100 younger adults (mean age: 21.6±2.5; 56 men and 
44 women) and 100 older adults (mean age: 70.1±7.3; 27 men 
and 73 women) with >12 years of education (with no mem-
ory disorders and they were self-sufficient in terms of daily 
activities).
Clinical sample was used to obtain PBAC sensitivity and 
specificity analysis. This group was formed by 30 AD pa-
tients (mean age: 73.7±5.7), 7 men and 23 women with 4 to 
11 years of education. Seventeen patients were recruited 
from a public hospital in Brasilia (HUB - Brasilia University 
Hospital) and thirteen from the IBNeuro - Brazilian Institute 
of Neuropsychology and Cognitive Sciences based on the cri-
teria of the National Institute of Neurological Disease and 
Communicative Disorders and Stroke Alzheimer’s Disease 
and Related Disorders Association (NINCDS-ADRDA). They 
had received a diagnosis of probable AD in their most current 
evaluation by a Medical and Neuropsychological Committee 
(ranging from 1 to 2 in Clinical Dementia Rating).
All subjects were screened for dementia using the MMSE1 
and the average scores were 29.1(0.9) to the young group, 
28.3(1.4) to the older group and 18.4(3.0) to AD patients. 
Written informed consent in accordance with the ethical 
guidelines for research with human subjects (196/96 CNS/
MS Resolution) was obtained from all participants and their 
caregivers (when appropriate). The study was approved by 
the Human Subjects Ethical Committee from the University 
of Brasilia.
Education profile was analyzed in younger adults, old-
er adults and AD patients. They were divided into four 
educational level groups: 1 to 4 years, 5 to 8 years, 9 to 11 
years, and more than 12 years of schooling (Table 1).
Instrument
The PBAC (3th brief version, 2010) was generously given by 
Professor Dr. David Libon7 (Department of Neurology, Drexel 
University College of Medicine, Philadelphia, Pennsylvania). 
It was translated (and back-translated) to a Brazilian ver-
sion by neuropsychologists fluent in English and Portuguese. 
Twenty-four young and six old adults were used as a pi-
lot study group in order to test the comprehension of the 
Brazilian translation.
This Brazilian version of the PBAC was individually ap-
plied to all subjects in a single session and in a fixed order. 
The number of points credited for the correct response varied 
in accordance with the task. SPSS/PASW (18.0 version) soft-
ware was used to statistical and data analysis.
The total PBAC (3th version) score ranges between 0 and 
100. The first version (2007) ranged between 0 and 1267. The 
principal component analysis yielded a five-factor solution 
related to executive control, processing speed, lexical access, 
semantic memory and episodic memory.
The PBAC working memory/mental search scale contains 
Letter Fluency Test [60 s to generate words with a specified 
letter (letter “F”)] and an Oral Version of the Trial Making Test, 
part B (linking numbers and letters; i.e., 1-A, 2-B, etc). Language 
scale contains five tests: naming, sentence writing, conversa-
tional speech and word reading. Visuospatial/visuoconstruc-
tional skills were assessed by three tests: copying a modified 
version of the Rey Complex Figure Test, line orientation and 
matching lines to a target in the non-line array. Episodic mem-
ory (verbal memory and learning) were scored with a four de-
pendent variables – number of words reproduced on the third 
learning trial of the word list, delayed free recall for a word 
list, delayed recognition test, delayed visual episodic memory 
(using a modified Rey Complex Figure Test). Social comport-
ment/behavior scale was assessed by clinical observation of 
six behavioral domains: apathy/poor initiation, disinhibition, 
social comportment, agitation/irritability, ritual/obsessive 
compulsive behavior and lack of empathy. 
Table 1. Distribution according to gender and education level 
for young, old and Alzheimer’s disease (AD) groups.
Young Old AD Total
Gender
Male 56 27 15 98
Female 44 72 16 132
Education
<4 years 0 5 12 17
5-8 years 0 6 11 17
9-11 years 6 22 6 34
>12 years 94 66 2 162
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RESULTS
Psychometrical analysis was performed to determine 
PBAC’s reliability and validity. Because unequal variances, a 
non-parallel estimate of reliability was performed (Cronbach’s 
alpha, α=0.804). Two components were extracted using prin-
cipal component analysis method to determine factorial va-
lidity. Only one PBAC task (Lecture) was obtained in a sec-
ond order factor in the factor intercorrelation matrix (0.772). 
Internal consistency was also obtained by Pearson correla-
tion (‘item-item’ and ‘test-item’) and all values were signifi-
cant at p<0.01.
The PBAC raw scores of all 230 participants were divid-
ed into three groups: younger 95.8(2.6), older adults 90.0(4.4) 
and AD patients 65(10.8). As noted here, there is little overlap 
between healthy old adults and AD patients.
An item analysis for each PBAC subtest within each of the 
five subscales (working memory/mental search, visuospatial 
functioning, language, verbal/visual episodic memory and 
social comportment/behavior) was conducted. A post-hoc 
one-way ANOVA Dunnett test showed significant differenc-
es (p<0.001) in memory, executive functions and visuospa-
tial tasks, but not in language [comparing younger and old-
er adults (p=0.147), younger and AD patients (p=0.93), older 
adults and AD patients (p=1.85)] and in behavior [younger 
and AD patients (p=0.159)]. 
To evaluate the difference in each task, t-test was used 
showing that there were differences in these same PBAC 
tasks between younger and older adults. However, there was 
no statistical difference between social behavior and lan-
guage (t=1.959, p=0.052) scores. 
Differences were observed between older adults and AD 
patients in all domains (Table 2), except behavior (t=1.976, 
p=0.057) and language (t=1.896, p=0.067) tasks. It is worth 
noting, however, that the values were close to the p<0.05 cri-
terion. Note that variances in MMSE and PBAC scores were 
higher in AD group (s.d=3.0 and 10.8, respectively) than the 
others groups. Average mean and standard error analysis of 
each PBAC subtest showed that slope was great in memory, 
followed by visuospatial abilities and executive functions.
Regarding gender, a multivariate analysis of variance 
(MANOVA) was performed using only younger and older 
adults data, and results revealed no significant differences 
among the groups in memory (F=2.27, p=0.133), executive 
functions (F=0.57, p=0.451), language (F=0.168, p=0.683) and 
behavior tasks. However, males performed better than fe-
males in visuospatial abilities tasks (F=8.56, p=0.004).
Possible correlations among the PBAC tasks were per-
formed using Pearson correlation. Age had a stronger negative 
correlation (r=-0.63) with memory and a weak negative cor-
relation with language tasks (r=-0.193). The PBAC raw scores 
were negatively correlated to age in the old group (r=-0.452, 
p<0.01), but not for AD group. The PBAC and MMSE were 
strongly correlated: r=0.897 (p<0.001, n=230). Regression R2 
value was 0.82. Correlations were calculated between PBAC 
and MMSE raw scores with young (r=0.115, p=0.253), old 
(r=0.38, p<0.001) and AD groups (r=0.697, p<0.001).
Excluding young group of the sample, the total area un-
der ROC curve (sensitivity versus 1-specificity) showed cut-
off point in PBAC (0.991, s.e.=0.05) scores.
dISCUSSIOn
In the present research, we described a relatively brief 
screening instrument that could be used within the context 
of clinical practice. The sensitivity of the PBAC to assess AD 
is supported by its robust correlation with the MMSE as 
found in this study and in a previous research7. However, 
education disparity is a problem in our study: higher educa-
tion level in healthy volunteers (mean above 12 years) com-
pared to the low level (4-11 years) in AD patients. Two do-
mains in the PBAC were not very sensitive: language and 
social comportment/behavior, and they should be excluded 
of raw score.
Some questions can properly be answered in this study. A 
major challenge for neuropsychological evaluation is distin-
guishing changes in some cognitive domains that occur dur-
ing the so-called “normal” aging and certain diseases, such 
as Alzheimer’s disease9-11. This is important because they 
Table 2. Mean, standard deviation and median of age, education, MMSE score   and PBAC tasks.
Y = young; O = old; AD = Alzheimer’s disease; PBAC: Philadelphia Brief Assessment of Cognition; MMSE: Mini-Mental State Examination.
* (p<0.001)
Young (n=100) Old (n=100) AD (n=30) t-test
Age (years) 21.6(2.5) 18-29 70.1(7.3) 60-89 73.7(5.7) 61-91 Y<O<AD*
Education ≥12 ≥5–12 >4<11 Y=O=>AD*
MMSE raw score 29.1(0.9) 29.3 28.3(1.4) 28.5 18.4(3.0) 17.9 Y > O > AD*
PBAC raw score 95.8(2.6) 96.3 90.0(4.4) 90.5 65.0(10.8) 62.5 Y > O > AD*
Memory 24.9(1.8) 25 21.1(3.0) 22 7.87(3.1) 7 Y > O > AD*
Executive function 10.2(1.7) 10 9.1(2.0) 9 7.9(3.1) 7 Y > O > AD*
Visuospatial ability 17.8(0.7) 18 16.9(1.2) 17 10.9(4.7) 11 Y > O > AD*
Language 18.9(0.3) 19 18.8(0.5) 19 18.1(1.9) 19 Y = O = AD
Behavior 24(0) 24 24(0) 24 23.8(0.4) 24 Y = O = AD
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may vary widely between individuals12. Results from Seattle 
Longitudinal Study13,14 showed that there is a large degree of 
overlap in younger, older and very older adults over several 
cognitive dimensions. In orientation, spatial vocabulary, in-
ductive reasoning, numerical abilities, immediate memory 
and daily activities tests a 90% overlap in scores was found 
between young and older adults up to 67 years-old. Inductive 
reasoning scores showed signs of cognitive decline after this 
point, in which the overlap was stable until age of 74 years-
old.
In neuropsychological evaluations, we seek to compare 
patients’ level of cognitive performance with the expected 
level of standard comparison. Significant discrepancies oc-
cur in one or more test scores enabling the cognitive func-
tioning assessment of psychiatric, educational or cultural 
impairment as is done in the patient’s experiences, consider-
ing their historical circumstances11,15,16 and emotional mem-
ories17-19. Several studies also suggest the effect of education 
level on the performance of cognitive tasks20.
The Brazilian version of the PBAC is quick and easy to 
apply and, in the sample studied, presented good screening 
evaluation instrument, differentiating patients with AD from 
the control group. Regarding gender, differential performance 
was observed only in visuospatial abilities, but the PBAC raw 
score had no gender influence.
Age differences had negative impacts on PBAC cognitive 
tasks, which were higher in memory than in language (Table 2). 
It is consistent with studies conducted by Salthouse13,14 based 
on 33 of their own studies with a total sample of almost 7,000 
subjects ranging from 18 to 95 years old. He concluded that 
age has a correlation of 0.63 with performed tasks to assess 
vocabulary, -0.31 with processing speed tasks, -0.15 and -0.48 
with memory tasks and the intelligence g factor. In turn, the g 
factor has a correlation of 0.97 with reasoning, 0.91 with spa-
tial abilities, 0.66 with memory, 0.60 and 0.73 with through 
and vocabulary13. Other studies used neuropsychological 
measures of attention, memory and visuospatial abilities in 
which individuals aged from 60 to 80 years had their perfor-
mance compared with individuals between 16 and 60 years 
of age12. Different tests have shown different rates of change 
between groups, being the memory test the first to show a 
significant decline11. In other tests, there was no evidence of 
significant change with increasing age21-23. These studies are 
important because they show that not all assessment tests 
are equally sensitive to the decline and that not all individu-
als experience a decline with the same intensity.
A test which compares strings of letters and symbols 
does not show any significant change in scores for all ages24. 
It was only by the age of 75 years means that the results of 
the tests in almost all areas were significantly lower than the 
average score of the control subjects. This great variability 
among the elderly people poses problems when one tries to 
assess the significance of test results for each patient24. The 
most consistent finding in both transverse and longitudinal 
studies is that the delayed recall scores of attention are more 
vulnerable to the impact of aging13. Since these functions are 
also central to Alzheimer’s disease symptoms, identifying the 
very early onset of this disease is complicated. Petersen and 
colleagues25 demonstrated in their classical research that 
recognition memory is relatively little affected by normal ag-
ing, but is especially sensitive in dementia.
Learning scores (i.e., acquisition) steadily declined with in-
creasing age and had no relation to scholarship level. Delayed 
recall (i.e., the rate of forgetting) remained relatively stable 
with age, when adjusted for the amount of early learned ma-
terial25. These results suggest a strategy for deciding wheth-
er a patient’s memory is impaired (learning, delayed recall 
or recognition memory scores drop below average levels). 
Screening tests such as the MMSE do not have many items 
to assess these cognitive domains7. PBAC screening test, in 
turn, evaluates them using a modified Rey Auditory Verbal 
Learning Test through these mnemonics domains.
In large cohort studies, declines in measures of delayed 
recall or accelerated forgetting were the best discriminators 
between patients with mild and non-dementia8,20,25,26. With 
increasing severity of illness, patients also have a constriction 
of immediate recall. Yet, these studies showed that patients 
may have impaired naming of objects, both in social interac-
tion or through formal tests, even that they did not show any 
language disturb10,15,27. Since early studies, there are some dis-
cussion as to whether or not a loss of appointment reflects 
semantic system dissolution in general or whether it is a true 
aphasic deficit16,28. Very early, researches have shown that the 
degree of anomia has been associated with rapid progression 
of Alzheimer’s disease29.
Tests results of line orientation (as used in PBAC test) can 
often be preserved and be useful to detect progressive visu-
ospatial dysfunction as Balint’s syndrome, visual agnosia or 
simultagnosia (unusual distribution of plaques and tangles 
in the visual cortex of association30).
On the other hand, a negative point is PBAC behavior task 
which makes a subjective evaluation about the participant’s 
behavioral changes. The main difficulty in this task is that 
researchers often do not have enough time or clinical train-
ing and this task should be performed by professionals with 
some diagnostic or assessment expertise. Perhaps for this 
reason ceiling effect was observed in this task. By contrast, 
this behavior task can be very useful in assessing psychiatric 
disorders which are quite common in dementia patients20.
In continuing PBAC studies to obtain clinical normative 
data, it is necessary to grade the participant’s dementia into 
groups based on clinical dementia rating (CDR) classifica-
tions and using different groups of dementia, such as fron-
totemporal dementia or mild cognitive impairment. Still, it 
is necessary to study a broader sample to obtain normative 
T-scores. 
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Taking into account the above mentioned aspects, the 
present work indicates that PBAC is a promising screening 
instrument for research and clinical purposes in Brazilian 
sample. However, in order to validate this instrument with 
reliability and validity for the Brazilian population, is nec-
essary to do a large sample test including representatives 
from different Brazilian regions and different education lev-
el groups.
1. Folstein MF, Folstein SE, Fanjiang G. MMSE: Mini-Mental State 
Examination Clinical Guide. Lutz, Fl: Psychological Assessment 
Resources, Inc.; 2001.
2. Lassonde M, Sauerwein HC, Gallagher A, Thériault M, Lepore F. 
Neuropsychology: traditional and new methods of investigation. 
Epilepsia 2006;47:9-13.
3. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity 
of cognitive impairment with and without dementia in an elderly 
population. Lancet 1997;349:1793-1796.
4. Howe L, Anderson AM, Kaufman DA, Sachs BC, Loring DW. 
Characterization of the Medical Symptom Validity Test in evaluation 
of clinically referred memory disorders clinic patients. Arch Clin 
Neuropsychol 2007;22:753-761.
5. Aggarwal A, Kean E. Comparison of the Folstein Mini Mental State 
Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) 
as a cognitive screening tool in an inpatient rehabilitation setting. 
Neurosci Med 2010;1:39-42.
6. Libon DJ, McMillan C, Gunawardena D, et al. Neurocognitive 
contributions to verbal fluency deficits in frontotemporal lobar 
degeneration. Neurology 2009;73:535-542.
7. Libon DJ, Xie SX, Moore P, et al. Patterns of neuropsychological 
impairment in frontotemporal dementia. Neurology 2007;68:369-375.
8. Morris RG, Worsley C, Matthews D. Neuropsychological assessment 
in older people: old principles and new directions. Adv Psychiatr Treat 
2000;6:362-370.
9. Alberini CM. Mechanisms of memory stabilization: are consolidation 
and reconsolidation similar or distinct processes? Trends Neurosci 
2005;28:51-56.
10. Ally BA, McKeever JD, Waring JD, Budson AE. Preserved frontal 
memorial processing for pictures in patients with mild cognitive 
impairment. Neuropsychologia 2009;47:2044-2055.
11. Bennett I, Golob E, Parker ES, Starr A. Memory evaluation in mild 
cognitive impairment using recall and recognition tests. J Clin Exp 
Neuropsychol 2006;28:1408-1422.
12. Baird A, Ford M, Podell K. Ethnic differences in functional and 
neuropsychological test performance in older adults. Arch Clin 
Neuropsychol 2007;22:309-318.
13. Deary IJ, Penke L, Johnson W. The neuroscience of human intelligence 
differences. Nat Rev Neurosci 2010;11:201-211.
14. Salthouse TA. When does age-related cognitive decline begin? 
Neurobiol Aging 2009;30:507-514.
15. Ardila A. Toward the development of a cross-linguistic naming test. 
Arch Clin Neuropsychol 2007;22:297-307.
16. Boone K, Victor T, Wen J, Razani J, Pontón M. The association between 
neuropsychological scores and ethnicity, language, and acculturation 
variables in a large patient population. Arch Clin Neuropsychol 
2007;22:355-365.
17. Satler C, Garrido LM, Sarmiento EP, Leme S, Conde C, Tomaz C. 
Emotional arousal enhances declarative memory in patients with 
Alzheimer’s disease. Acta Neurol Scand 2007;116:355-360.
18. Satler C, Uribe C, Conde C, Da-Silva SL, Tomaz C. Emotion processing 
for arousal and neutral content in Alzheimer’s disease. Int J Alzheimers 
Dis 2010;1:1-6.
19. Charles ST, Mather M, Carstensen LL. Aging and emotional memory: 
The forgettable nature of negative images for older adults. J Exp 
Psychol Gen 2003;132:310-324.
20. Woodford HJ, George J. Cognitive assessment in the elderly: a review 
of clinical methods. QJM 2007;100:469-484.
21. Calero M, Navarro E. Cognitive plasticity as a modulating variable 
on the effects of memory training in elderly persons. Arch Clin 
Neuropsychol 2007;22:63-72.
22. Delis D, Wetter S. Cogniform disorder and cogniform condition: 
proposed diagnoses for excessive cognitive symptoms. Arch Clin 
Neuropsychol 2007;22:589-604.
23. Denburg NL, Buchanan TW, Tranel D, Adolphs R. Evidence for 
preserved emotional memory in normal older persons. Emotion 2003; 
3:239-253.
24. Nelson EA, Dannefer D. Aged heterogeneity: fact of fiction? The 
fate of diversity in gerontological research. Gerontologist 1992; 
32:17-23.
25. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG. Memory 
funcion in normal aging. Neurology 1992;42:396-401.
26. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised 
instrument for the diagnosis of mental disorder in the elderly with 
special reference to the early detection of dementia. Br J Psychiatry 
1986;149:698-709.
27. Aretouli E, Brandt J. Episodic memory in dementia: characteristics 
of new learning that differentiate Alzheimer’s, Huntington’s, 
and Parkinson’s diseases. Arch Clin Neuropsychol 2010;25: 
396-409.
28. Samuel AG. Speech perception. Annu Rev Psychol 2011;62:49-72.
29. Salmon DP, Bondi MW. Neuropsychological assessment of dementia. 
Annu Rev Psychol 2009;60:257-282.
30. Giovagnoli AR, Aresi A, Reati F, Riva A, Gobbo C, Bizzi A. The 
neuropsychological and neuroradiological correlates of slowly 
progressive visual agnosia. Neurol Sci 2009;30:123-131.
References
